California Healthcare Institute
CALIFORNIA BIOMEDICAL LEADERS WEIGH IN ON HEALTHCARE REFORM
During the debate on healthcare reform in 2009, one of the most important voices in that national discussion was that of the innovator biomedical community. California, as the state with the largest cluster of biomedical research companies in the U.S., was looked to for leadership on several key issues such as comparative effectiveness, regulatory reform, biosimilars, and more — all critical to the biomedical industry in healthcare reform. In November of 2009, California biomedical leaders from across the state gathered in San Francisco to discuss these issues. In particular, they were exploring ho they could establish a dialogue with state and federal officials on their concerns. The result, ” The California Healthcare Institutes Policy Forum – 2009″ provided deep insight not only to the California biomedical community, but also to Washington, DC, and the nation.
- Comparative Effectiveness – Hans Bishop, President, Specialty Medicine, Bayer HealthCare LLC, discussed his experiences in Europe with comparative effectiveness in various nations.
- HIV Treatments – John C. Martin, Ph.D., Chairman of the Board & CEO, Gilead Sciences, reviewed the potential impact of Healthcare Reform on HIV research & development, and continuing treatments.
- Devices & Diagnostics – Carl W. Hull, President & CEO, Gen-Probe Incorporated talked about the prospect of healthcare reform and how he believed it would impact the continuing development of innovative devices and diagnostics.
Key NHD Services:
- Website Landing Page – NHD created a fully compatible “The California Healthcare Institutes Policy Forum – 2009″ landing page that was directly connected to the existing CHI website. This allowed access to the information on the forum from either the CHI website, or through a direct link to the landing page.
- “SmartCasts” – A series of video enhanced emails called “SmartCasts” were produced and created by NHD for CHI. These were sent to CHI members, CA legislators, and Members of Congress in Washington, DC. Key CA media were also targeted. The “opens,” “plays,” and other actions taken by the target audience were tracked and reported to CHI. Analytical results from the “SmartCasts” were substantial and utilized in CHI’s forum follow up.
- On-Demand Videos – Eight “On-Demand” video “chapters” were created from the CHI Policy Forum – 2009 dialogue shot by NHD. Each “chapter” covered key issues important to the California and national biomedical industry. The “chapters” were designed to deliver maximum information in a short, compelling video. Again, all of the “On-Demand” video activity was tracked and analyzed. As with the “SmartCast,” interesting analytical insights were gathered by NHD and presented to CHI.